Avoro Capital Advisors LLC Global Blood Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $45.7 Million - $81.9 Million	-1,000,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $2.27 Million - $2.9 Million	50,000 Added 5.26%	1,000,000 $48.5 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $24 Million - $32.1 Million	600,000 Added 171.43%	950,000 $50.3 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $1.97 Million - $2.92 Million	62,500 Added 21.74%	350,000 $14.4 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $15.7 Million - $21.1 Million	-413,048 Reduced 58.96%	287,500 $10.9 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $41.2 Million - $53.4 Million	-1,065,000 Reduced 60.32%	700,548 $31.7 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $3.02 Million - $5.03 Million	-76,348 Reduced 4.15%	1,765,548 $85.3 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $21.3 Million - $32.8 Million	717,596 Added 63.83%	1,841,896 $72.5 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $28.2 Million - $34.9 Million	1,124,300	1,124,300 $34.9 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.